Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane in TAC for Neoadjuvant Breast Cancer
NCT01647672Phase 3Unknown
- Sponsor
- Tianjin Medical University
- Start
- Jan 2012
- Primary completion
- Dec 2012
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nab-paclitaxel in breast cancer, sponsored by Tianjin Medical University. Status: unknown.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01647672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01647672.